PHAR
Pharming Group N.V.Company with tickers: PHAR
CIK
1828316
CUSIP
71716E105
Shares Outstanding
70,625,230
13F Activity (30d)
9 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-06-04 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-04-16 | — | |
| 20-F | 2026-04-02 | 2025-12-31 | |
| 6-K | 2026-04-02 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-24 | — | |
| 6-K | 2026-03-12 | — | |
| 6-K | 2026-02-03 | — | |
| 6-K | 2026-02-02 | 2026-02-01 | |
| 6-K | 2026-01-08 | — | |
| 6-K | 2025-11-06 | — | |
| 6-K | 2025-10-22 | 2025-10-20 | |
| 6-K | 2025-10-06 | — | |
| 6-K | 2025-10-01 | — | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-09-02 | — | |
| 6-K | 2025-07-31 | — | |
| 6-K | 2025-06-24 | — | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-05-08 | — | |
| 6-K | 2025-04-30 | — | |
| 6-K | 2025-04-25 | — | |
| 6-K | 2025-04-23 | — | |
| 6-K | 2025-04-03 | — | |
| 20-F | 2025-04-03 | 2024-12-31 | |
| 6-K | 2025-03-20 | — | |
| 6-K | 2025-03-13 | — | |
| 6-K | 2025-03-04 | — | |
| 6-K | 2025-02-20 | — | |
| 6-K | 2025-02-07 | — | |
| 6-K | 2025-01-21 | — | |
| 6-K | 2024-12-16 | 2024-12-15 | |
| 6-K | 2024-12-11 | — | |
| 6-K | 2024-10-24 | — | |
| 6-K | 2024-10-10 | — | |
| 6-K | 2024-09-26 | — | |
| 6-K | 2024-08-01 | — | |
| 6-K | 2024-05-30 | — | |
| 6-K | 2024-05-21 | — | |
| 6-K | 2024-05-15 | — | |
| 6-K | 2024-05-08 | — | |
| 6-K | 2024-04-25 | — | |
| 6-K | 2024-04-24 | — | |
| 6-K | 2024-04-08 | — | |
| 20-F | 2024-04-04 | 2023-12-31 | |
| 6-K | 2024-04-04 | — | |
| 6-K | 2024-03-14 | — |
Showing 1–50 of 112 filings